Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

(19) (712) 1,797 (1,109)

Gain on extinguishment of

development financing

obligation - - - 31,592

Gain on sale of products 715 - 5,860 -

Net loss (60,020) (20,535) (138,826) (59,391)

Beneficial conversion

feature - (18,419) - (21,920)

Loss attributable to common

stockholders $(60,020) $(38,954) $(138,826) $(81,311)

Loss per share attributable

to common stockholders,

basic and diluted $(2.53) $(2,043.15) $(10.04) $(6,254.69)

Weighted-average common

shares used in computing

loss per share attributable

to common stockholders,

basic and diluted 23,694 19 13,829 13

JAZZ PHARMACEUTICALS, INC.

SUMMARY OF PRODUCT SALES, NET

(In thousands)

(Unaudited)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Xyrem $11,120 $8,082 $39,018 $29,049

Antizol 3,740 3,472 14,153 12,813

Cystadane (1) - 336 365 1,437

Total $14,860 $11,890 $53,536 $43,299

(1) Jazz Pharmaceuticals, Inc. sold its rights to Cystadane to an

unrelated third party in March 2007.

JAZZ PHARMACEUTICALS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands)


'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015 Esperance Pharmaceuticals Inc. today reported positive ... EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 ... destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) ... a wide range of cancers. Results ... EP-100 were presented at the 2015 ASCO Annual ...
(Date:6/1/2015)... May 29, 2015 Research and ... addition of the "2015 Strategies in ... to their offering. This new ... immunoprotein diagnostic market, including emerging tests, technologies, ... profiles of leading suppliers. Companies ...
(Date:6/1/2015)... Research and Markets( http://www.researchandmarkets.com/research/5j2hpk/2015_strategies ) ... "2015 Strategies in the US Point-of-Care/POC Clinical ... This new 373-page report contains ... of the POC clinical chemistry market, including ... trends, competitive landscape, and emerging opportunities for ...
(Date:6/1/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/n2rvxp/2015_assessments ... "2015 Assessments of Leading Microbiology Market ... Market Entrants" report to their offering. ... VPGMarketResearch.com provides insightful profiles of leading microbiology ... The report presents strategic assessments, including ...
Breaking Biology Technology:Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3Assessments of Leading Microbiology Market Players 2015 - Profiles of Major Suppliers and Recent Market Entrants 2
... MADISON, WI. - EraGen Biosciences , a ... commercializes products and technologies that accelerate the drug ... announced today that it has selected ITOCHU ... distribute its integrated phylogenomics product, Master Catalog ...
... Wisconsin Technology Network has received from NorthStar Economics an ... primer for Wisconsin companies seeking information about risk capital ... have agreed to exclusively excerpt their report in four-installments ... , , Seed-Stage Venture Financing , , Seed-Stage ...
... are focused on being profitable and productive. Technology ... years, you'll see an increase in the adoption of ... businesses. Our local businesses will incorporate technology to ... dollars through their doors. , ,There are ...
Cached Biology Technology:EraGen Expands in Japan 2Seed-Stage Venture Financing 2Seed-Stage Venture Financing 3Seed-Stage Venture Financing 4Seed-Stage Venture Financing 5Doing it Right: Business IT Fusion for the Future 2Doing it Right: Business IT Fusion for the Future 3
(Date:4/27/2015)... more than four decades, AUVSI,s Unmanned Systems ... event for the unmanned land, sea, and air industries. ... local, national, or trade news organization interested in gathering ... applications of unmanned technologies. The conference will explore the ... and how it will soon impact the lives of ...
(Date:4/21/2015)... , April 21, 2015 ... evolving government policies are boosting access control systems market ... According to a recently published report by TechSci ... 2020 ", the access control systems market in ... USD1.2 billion by 2020.The access control systems market in ...
(Date:4/17/2015)... , April 17, 2015 ... concerns, and technological advancement to drive biometric systems ... until 2020   According to a ... Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... to register growth at CAGR of over 22% ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... Medicine, Hershey, Pennsylvania have discovered that the efficacy of ... antiviral and antitumor activity, is dependent on the Opioid ... This discovery, reported in the August 08 issue ... insights into a widely used drug that may lead ...
... and the University of Texas at Austin have found ... to prevent or tolerate errors in protein production. ... in protein production may lie in the malformed proteins ... proteins can build up in long-lived cells, like neurons, ...
... PAUL (July 24, 2008) A multi-institutional team of ... School, have developed a powerful tool for genomic research ... generate synthetic enzymes that can target and manipulate DNA ... discovery is great, said Dan Voytas, Ph.D., director of ...
Cached Biology News:Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3Consortium develops new method to manipulate genetic material 2
... system, 100-240 V, uses xMAP technology for ... proteins and peptides in one microplate well. ... to 100 color-coded bead sets, each of ... reactant (enzyme substrates, receptors, antigens, or antibodies) ...
Cell Culture Flask, 75 cm, treated polystyrene...
...
... style shaker flasks have three extra deep ... solutions to improve oxygen or gas transfer ... The long neck reduces splashing and is ... wall thickness provides the proper balance between ...
Biology Products: